数据
资源
版本对比
免费注册
预约演示
免费注册
Advanced Liver Cancer
Drug Pipeline Prospers with an Inrush
2021-04-30
·
GlobeNewswire
基因疗法
生物类似药
免疫疗法
Los Angeles, USA, April 29, 2021 (GLOBE NEWSWIRE) --
Advanced Liver Cancer
Drug Pipeline Prospers with an Inrush of Pharma Companies and Emerging Novel Therapies A comprehensive analysis of 50+ key companies and 50+ emerging therapies enriching the
Advanced Liver Cancer
Pipeline Landscape. DelveInsight’s ‘
Advanced Liver Cancer
Pipeline Insights’ report provides a holistic view of the pipeline therapies that are under development in pre-clinical as well as clinical stages of development and growth prospects across the
Advanced Liver Cancer
domain. Some of the key highlights from the
Advanced Liver Cancer
pipeline report are: In the News Got queries? Want to know more? Request for Sample @
Advanced Liver Cancer
Clinical Trial Analysis and Pipeline Insights
Advanced Liver Cancer
Pipeline Activity: At a Glance Reach out @
Advanced Liver Cancer
Pipeline: Novel therapies and emerging technologies Advanced
Liver Cancer
Pipeline Agent Assessment The Advanced
Liver Cancer
Pipeline report lays down holistic coverage of active pipeline assets segmented by Stage, Product Type, Route of Administration, Molecule Type, Target, and Indications of various drugs. By Product Type By Stage By Molecule Type By Route of Administration By Mechanism of Action By Targets By Stage and Route of AdministrationBy Stage and Product Type For more information on emerging drugs, visit
Advanced Liver Cancer
Pipeline: Emerging Therapies and Trends Scope of the Report Coverage: GlobalKey Players: Siranomics,
Novartis
,
Yiviva
,
Eisai
,
CAS Lamvac Biotech
, Benhealth Biopharmaceutical,
Chia Tai Tianqing Pharmaceutical
,
Surface Oncology
,
Zai Lab
(Shanghai),
Can-Fite Biopharma
,
Suzhou Zelgen Biopharmaceuticals
,
Innovent Biologics
,
SignalRX Pharmaceuticals
,
Carsgen Therapeutics
,
Shanghai Henlius Biotech
,
Jiangsu HengRui Medicine
,
Leap Therapeutics
,
Eureka Therapeutics
, and many more.Key
Advanced Liver Cancer
Pipeline Therapies:
STP 705
,
PDR001
, YIV-906,
H3B 6527
, Plasmodium Immunotherapy, Activated CIK, AK105 Injection, SRF 388,
MGD013
,
Namodenoson
,
SHR-1210
,
ET140203
,
PLM60
,
INC280
, Donafenib,
IBI308
,
SF1126
, CAR-GPC3 T Cells, HLX10, and many more. Have a walkthrough of the report @
Advanced Liver Cancer
Emerging Pipeline Key Questions Answered Need to clarify something? Get in touch @
Advanced Liver Cancer
Drug Pipeline Insights Table of Contents Visit to know more of what’s covered @
Advanced Liver Cancer
Emerging Therapies Other Insightful Reports
Liver cancer
IncidenceRead about the rising global burden of
Liver Cancer
. Excessive Daytime Sleepiness MarketGet a comprehensive analysis of epidemiology, pipeline therapies, and kye companies including
Bioprojet Pharma/Harmony Biosciences
,
Axsome Therapeutics
,
Jazz Pharmaceuticals
,
BenevolentAI Bio
, and many others. Bevacizumab Biosimilars InsightCoverage of about 40+ companies and 40+ marketed and pipeline drugs in Bevacizumab Biosimilars landscape.
Pegfilgrastim
Biosimilar InsightComprehensive insights about 20+ companies and 20+ marketed and pipeline drugs in
Pegfilgrastim
Biosimilars landscape. Different Types of Alternative MedicineKnow more about the state of Alternative Medicine in Healthcare and their changing landscape. Adeno-Associated Virus (AAV) Vectors in Gene TherapyAnalysis of emerging therapies and key companies including
Pfizer
(previously
Sangamo Biosciences
),
NightstaRx Ltd
, a
Biogen Company
,
MeiraGTx
,
Neurocrine
Biosciences/
Voyager Therapeutics
,
Roche
(previously
Spark Therapeutics
)/Pfizer,
Sangamo Therapeutics
,
Freeline Therapeutics
,
Spark Therapeutics
,
Asklepios Biopharmaceutical
(Actus Therapeutics),
Audentes Therapeutics
,
Roche/Sarepta Therapeutics
,
Horama S.A.
,
MeiraGTx UK II Ltd
, RegenxBio,
Sangamo Therapeutics
,
Amicus Therapeutics
,
Amicus Therapeutics
, and several others.
Angelman Syndrome
Angelman Syndrome
MedicationsA rich analysis of emerging drug therapies and key companies such as
GeneTX Biotherapeutics, LLC
,
Ultragenyx Pharmaceutical Inc
,
Hoffmann-La Roche
,
Ovid Therapeutics Inc.
,
Biogen
, and others involved in the
Angelman Syndrome
market. Get in-depth knowledge of the healthcare and pharma world through DelveInsight's Competitive Intelligence Services and Business Solutions. About DelveInsight DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports
Pharma
companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve. For more insights, visit
Pharma
, Healthcare, and Biotech News
机构
Neurocrine Biosciences, Inc.
再鼎医药(上海)有限公司
Yiviva, Inc.
[+39]
适应症
肝癌
天使综合征
靶点
-
药物
H3B-6527
ET1402L1-CART
信迪利单抗
[+9]
标准版
¥
16800
元/账号/年
新药情报库 | 省钱又好用!
立即使用
热门报告
全球潜力靶点及FIC产品研究调研报告
智慧芽生物医药
肿瘤领域药物开发早期热门靶点研究报告(AACR 2023-2024)
智慧芽生物医药
siRNA药物Amvuttra专利调研实务指南
智慧芽生物医药
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
开始免费试用
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。
试用数据服务